Search results

Oxfam reaction to the announcement by the European Commission that $10.4 billion had been raised to fund the research and development of vaccines, treatments and tests for the coronavirus.  

In 2011, following decades of isolation, Myanmar embarked on an unprecedented reform process, raising hopes for a new democracy.

A one-off 99 percent levy on billionaires’ wealth gains during the pandemic could pay for everyone on Earth to be vaccinated against COVID-19 and provide a $20,000 cash grant to all unemployed workers, according to new analysis released today by Oxfam, the Fight Inequality Alliance, the Institute for Policy Studies and the Patriotic Millionaires.

More money for Development is always welcome especially as there are strong needs for investment in infrastructure. The new Asian Infrastructure Investment Bank must put fighting poverty and inequality at the heart of its mission.

In reaction to Pfizer’s announcement of voluntary licenses of its COVID-19 oral antiviral treatment Paxlovid to the Medicines Patent Pool, People’s Vaccine Alliance spokesperson and Oxfam America’s Senior Advocacy Advisor, Robbie Silverman, said: “Pfizer’s announcement to voluntarily licence the COVID treatment Paxlovid is welcome but is far from enough."     

European austerity programs have dismantled the mechanisms that reduce inequality and enable equitable growth.

Millions of poor people will go without life-saving food and medicines as donor aid pledges to poor countries are breached.

Refugees living in camps are sharing one tap between up to 250 people and many have less than3.5 square meters of living space per person which will make it extremely difficult to contain the coronavirus outbreak, Oxfam said today.

Vaccinating the poorest half of humanity —3.7 billion people— against coronavirus could cost less than what the ten biggest pharmaceutical companies make in four months, Oxfam said today. 

Comment ahead of the Vaccine Alliance pledging conference tomorrow (4 June) that is expected to raise at least US$ 7.4 billion to support the roll out of vaccination programs across the developing world, and establish a new fund to help developing countries buy and distribute a coronavirus vaccine.